[1]
T. V. THOMAS, A. THAKUR, and A. KUMAR S., “EXPANSION STRATEGIES TO DESIGN HYBRID MOLECULES OF FDA APPROVED DRUGS AS POTENTIAL INHIBITORS OF SARS Co-V-2 MAIN PROTEASE (Mpro)”, Int J App Pharm, vol. 17, no. 2, pp. 153–164, Mar. 2025.